Get your free personalized podcast brief

We scan new podcasts and send you the top 5 insights daily.

Historically, patient data was built for human analysis via dashboards. To enable timely interventions by human and AI agents, data must now be structured as "execution-ready" and actionable in the moment, shifting the entire data architecture's purpose from reflection to action.

Related Insights

We possess millions of data points on interventions, but they are useless to AI models because they're trapped in thousands of disparate EMRs in varied formats. The challenge is not generating more data, but solving the human incentive and alignment problems required to create unified data registries.

The need to power AI agents has created extreme urgency for enterprises to get their data in order. The focus is no longer just storing data, but breaking down silos, ensuring quality, and establishing strong governance so automated systems can use the information effectively and reliably.

AI-powered platforms transform how leaders consume insights. Instead of passively receiving periodic reports from a central analyst, leaders are empowered to pull real-time information on demand for immediate needs. This enables more timely decision-making without creating an analytical bottleneck.

The ultimate goal of a connected patient data ecosystem is to shift from reactive support to genuinely anticipatory care. In the near future, AI agents will sense and predict risks—like non-adherence or access barriers—and trigger interventions before the patient or their physician even encounters the problem.

Patients and providers increasingly use AI agents for advice, but these tools often fail because their underlying data lacks semantic context. To provide relevant, personalized responses instead of generic ones, data must be enriched to understand the patient's specific situation and journey.

The key "no-regret" move for pharma data teams is to abandon serving all use cases from one giant table. Instead, they should structure data into layered products: foundational (transactions), functional (KPIs), fit-for-use-case (decisions), and fit-for-AI (semantic context).

The primary challenge holding back precision medicine is not a lack of data or innovation. Instead, it's the operational difficulty of integrating and interpreting complex, siloed information quickly enough to make it clinically actionable for individual patients. The focus must shift from accumulation to execution.

The true potential of AI agents is locked behind messy, disorganized corporate data. This has forced a renewed, urgent focus on foundational data work, like warehousing and cleanup, as companies realize that AI requires a data architecture built for agents, not just dashboards.

Future AI agents will move beyond reactive task completion. By integrating and analyzing vast, siloed datasets—like health metrics from a smartwatch, calendar events, and genetic factors—they can proactively identify patterns and offer insights a human would miss, such as connecting health symptoms to specific behaviors.

The main driver for centralizing data is shifting from business intelligence to providing essential context for AI agents. Without a unified data source, agents are as limited as pre-internet ChatGPT, unable to understand current business realities.